Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Interest Expenses (2016 - 2025)

Historic Interest Expenses for vTv Therapeutics (VTVT) over the last 11 years, with Q3 2025 value amounting to $5000.0.

  • vTv Therapeutics' Interest Expenses changed N/A to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5000.0, marking a year-over-year decrease of 2857.14%. This contributed to the annual value of $13000.0 for FY2023, which is 1333.33% down from last year.
  • vTv Therapeutics' Interest Expenses amounted to $5000.0 in Q3 2025.
  • In the past 5 years, vTv Therapeutics' Interest Expenses registered a high of $8000.0 during Q3 2022, and its lowest value of $1000.0 during Q1 2022.
  • In the last 4 years, vTv Therapeutics' Interest Expenses had a median value of $6000.0 in 2021 and averaged $5000.0.
  • Its Interest Expenses has fluctuated over the past 5 years, first crashed by 9744.68% in 2021, then surged by 3333.33% in 2022.
  • Over the past 4 years, vTv Therapeutics' Interest Expenses (Quarter) stood at $6000.0 in 2021, then changed by 0.0% to $6000.0 in 2022, then grew by 16.67% to $7000.0 in 2023, then fell by 28.57% to $5000.0 in 2025.
  • Its last three reported values are $5000.0 in Q3 2025, $7000.0 for Q4 2023, and $4000.0 during Q3 2023.